Overview

Thoracal Radiotherapy and Tarceva

Status:
Terminated

Trial end date:
2020-12-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if erlotinib given orally along with concurrent palliative irradiation to lung cancer improves local control compared to those treated with radiotherapy alone.

Phase:

Phase 2

Details

Lead Sponsor:

Oslo University Hospital

Treatments:

Erlotinib Hydrochloride